BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19157947)

  • 1. Invasive fungal infections and (1,3)-beta-D-glucan serum concentrations in long-term intensive care patients.
    Presterl E; Parschalk B; Bauer E; Lassnigg A; Hajdu S; Graninger W
    Int J Infect Dis; 2009 Nov; 13(6):707-12. PubMed ID: 19157947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-diagnostic kinetics of the (1 → 3)-β-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia.
    Koo S; Baden LR; Marty FM
    Clin Microbiol Infect; 2012 May; 18(5):E122-7. PubMed ID: 22404638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Value of sTREM-1, PCT, and 1,3-
    Yan L; Li Y; Wu C; Shi Y; Kong C
    Biomed Res Int; 2022; 2022():6095441. PubMed ID: 35937405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza-associated invasive aspergillosis in patients admitted to the intensive care unit in Sweden: a prospective multicentre cohort study.
    Krifors A; Blennow O; Påhlman LI; Gille-Johnson P; Janols H; Lipcsey M; Källman J; Tham J; Stjärne Aspelund A; Ljungquist O; Hammarskjöld F; Hällgren A; De Geer L; Lemberg M; Petersson J; Castegren M
    Infect Dis (Lond); 2024 Feb; 56(2):110-115. PubMed ID: 37897800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of invasive fungal diseases in non-neutropenic ICU patients, with focus on candidiasis and aspergillosis: a comprehensive review.
    Azim A; Ahmed A
    Front Cell Infect Microbiol; 2024; 14():1256158. PubMed ID: 38505289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between Wako-WB003 and Fungitec G tests for detection of (1-->3)-beta-D-glucan in systemic mycosis.
    Hossain MA; Miyazaki T; Mitsutake K; Kakeya H; Yamamoto Y; Yanagihara K; Kawamura S; Otsubo T; Hirakata Y; Tashiro T; Kohno S
    J Clin Lab Anal; 1997; 11(2):73-7. PubMed ID: 9058239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-(1→3)-D-glucan- and mannan-guided early termination of antifungal therapy in ICU patients: a randomized controlled study.
    Erb T; Mihai S; Strauß R; Herbst L; Castellanos I; Diesch K; Cipa F; Bihlmaier K; Lang A-K; Ganslmayer M; Willam C; Bremer F; Fürst J; Beyer C; Bogdan C; Rath A; Held J
    Antimicrob Agents Chemother; 2023 Nov; 67(11):e0072523. PubMed ID: 37823695
    [No Abstract]   [Full Text] [Related]  

  • 8. Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM.
    Bassetti M; Giacobbe DR; Agvald-Ohman C; Akova M; Alastruey-Izquierdo A; Arikan-Akdagli S; Azoulay E; Blot S; Cornely OA; Cuenca-Estrella M; de Lange DW; De Rosa FG; De Waele JJ; Dimopoulos G; Garnacho-Montero J; Hoenigl M; Kanj SS; Koehler P; Kullberg BJ; Lamoth F; Lass-Flörl C; Maertens J; Martin-Loeches I; Muñoz P; Poulakou G; Rello J; Sanguinetti M; Taccone FS; Timsit JF; Torres A; Vazquez JA; Wauters J; Asperges E; Cortegiani A; Grecchi C; Karaiskos I; Le Bihan C; Mercier T; Mortensen KL; Peghin M; Rebuffi C; Tejada S; Vena A; Zuccaro V; Scudeller L; Calandra T;
    Intensive Care Med; 2024 Apr; 50(4):502-515. PubMed ID: 38512399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological indicators and predictors of lethality associated with fungal infections in a NICU: a historical series.
    Menezes RP; Ferreira ICDS; Lopes MSM; de Jesus TA; de Araújo LB; Santos Pedroso RD; Röder DVDB
    J Pediatr (Rio J); 2024; 100(3):267-276. PubMed ID: 38145630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Roles of (1→3)-β-D-Glucan in Cerebrospinal Fluid for Detection and Therapeutic Monitoring of Invasive Fungal Diseases of the Central Nervous System.
    Walsh TJ; Zhang SX
    Clin Infect Dis; 2024 Jan; 78(1):11-14. PubMed ID: 37650506
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 and fungal infections: Etiopathogenesis and therapeutic implications.
    Chumbita M; Puerta-Alcalde P; Garcia-Pouton N; García-Vidal C
    Rev Esp Quimioter; 2021 Sep; 34 Suppl 1(Suppl1):72-75. PubMed ID: 34598433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global incidence and mortality of severe fungal disease.
    Ikuta KS; Meštrović T; Naghavi M
    Lancet Infect Dis; 2024 May; 24(5):e268. PubMed ID: 38395046
    [No Abstract]   [Full Text] [Related]  

  • 13. Global incidence and mortality of severe fungal disease - Author's reply.
    Denning DW
    Lancet Infect Dis; 2024 May; 24(5):e269. PubMed ID: 38395047
    [No Abstract]   [Full Text] [Related]  

  • 14. Retracted: Clinical Value of sTREM-1, PCT, and 1,3-
    International BR
    Biomed Res Int; 2024; 2024():9785756. PubMed ID: 38230145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index.
    Posteraro B; De Pascale G; Tumbarello M; Torelli R; Pennisi MA; Bello G; Maviglia R; Fadda G; Sanguinetti M; Antonelli M
    Crit Care; 2011; 15(5):R249. PubMed ID: 22018278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease.
    Acosta J; Catalan M; del Palacio-Pérez-Medel A; Montejo JC; De-La-Cruz-Bértolo J; Moragues MD; Pontón J; Finkelman MA; del Palacio A
    Eur J Clin Microbiol Infect Dis; 2012 May; 31(5):721-31. PubMed ID: 21811868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective survey of (1→3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting.
    Mohr JF; Sims C; Paetznick V; Rodriguez J; Finkelman MA; Rex JH; Ostrosky-Zeichner L
    J Clin Microbiol; 2011 Jan; 49(1):58-61. PubMed ID: 21048005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Changing Landscape of Invasive Fungal Infections in ICUs: A Need for Risk Stratification to Better Target Antifungal Drugs and the Threat of Resistance.
    Poissy J; Rouzé A; Cornu M; Nseir S; Sendid B
    J Fungi (Basel); 2022 Sep; 8(9):. PubMed ID: 36135671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is ß-d-glucan Relevant for the Diagnosis and Follow-Up of Intensive Care Patients with Yeast-Complicated Intra-Abdominal Infection?
    Dupont H; Malaquin S; Villeret L; Macq PY; Ammenouche N; Tinturier F; Diouf M; Rumbach M; Chouaki T
    J Fungi (Basel); 2022 May; 8(5):. PubMed ID: 35628743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for Invasive Candida Infection in Critically Ill Patients: A Systematic Review and Meta-analysis.
    Thomas-Rüddel DO; Schlattmann P; Pletz M; Kurzai O; Bloos F
    Chest; 2022 Feb; 161(2):345-355. PubMed ID: 34673022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.